Tag: Medicines for Europe
-
European Study Highlights Falling Prices, Higher Costs, and Shortages in AMR Treatments
Overview: What the European study found During World AMR Awareness Week, an independent European study presented by Viatris and Medicines for Europe sheds light on a complex trend impacting antimicrobial resistance (AMR) treatment: prices are falling, costs are rising, and shortages are increasingly common. The report synthesizes data from multiple European markets, comparing recent price…
-
European study links falling prices, rising costs, and shortages in AMR-linked antibiotics
Overview: European study links price declines to mounting costs and shortages As World Antimicrobial Resistance (AMR) Awareness Week begins, a new independent European study presented during the event highlights a troubling paradox in the antibiotic supply chain: availability is tightening while prices fall and costs rise in different parts of the market. The findings, disclosed…
-
European study finds falling prices, rising costs and shortages in antibiotics amid AMR concerns
European study highlights a paradox in antibiotic markets A new independent study presented during World AMR Awareness Week sheds light on a troubling paradox in Europe’s antibiotic market. Conducted under the auspices of Viatris and Medicines for Europe, the analysis shows falling list prices for several antibiotics while manufacturers and distributors report rising input costs…